Wednesday, Mar 19 2025 | Time 21:37 Hrs(IST)
Business EconomyPosted at: Feb 13 2025 8:05PM


Jubilant Biosys seals deal with Pierre Fabre SA

New Delhi, Feb 13 (UNI) Jubilant Biosys Innovative Research Services Pte Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys Limited, has executed the transaction definitive agreements with Pierre Fabre SA, and its affiliate entities, for JBIRSPL to acquire 80 percent equity capital in JASMIN (new company incorporated by PF in France), with remaining 20 percent retained by PF.
At closing of the transaction, JASMIN shall acquire Pierre Fabre’s R&D Centre (including R&D Site and R&D activities) at Saint-Julien-en-Genevois, France, and JBIRSPL would also execute a Shareholders’ Agreement and other transition agreements with PF.
This strategic agreement will enable Jubilant Biosys Limited to expand its footprint in Europe in areas like Biologics (mAbs) and Antibody Drug Conjugate (ADC), in addition to its existing services including integrated drug discovery services from India.

Speaking on the announcement, Giuliano Perfetti, CEO & Managing Director, Jubilant Biosys said, “We are thrilled to have reached this strategic agreement with Pierre Fabre. Our R&D site in Saint-Julien-en-Genevois will serve as a Center of Excellence for biologics and ADCs, located at the heart of Europe."
This expansion strengthens our presence and fosters collaboration with both biotech and large pharma companies in Europe and the USA. By combining the scientific expertise in biologics and ADCs at Saint-Julien-en-Genevois with the capabilities of 1,200 scientists in India we establish a comprehensive service offering for accelerated delivery of early chemistry, discovery biology, DMPK, integrated drug discovery and CDMO for intermediates and APIs.
With this strategic move, Jubilant Biosys Limited advances its "CRDMO Partner in Science" strategy and reinforces its commitment to delivering innovative solutions to global pharmaceutical customers, he added.
UNI SKB CS2004
Please log in to get detailed story.
Tags: #Jubilant Biosys seals deal with Pierre Fabre SA
More News
Jitan Ram Manjhi inaugurates Build Bharat Expo 2025

Jitan Ram Manjhi inaugurates Build Bharat Expo 2025

19 Mar 2025 | 8:08 PM

New Delhi, Mar 19 (UNI) Union MSME Minister Jitan Ram Manjhi has inaugurated Build Bharat Expo 2025 with a grand inaugural ceremony at Bharat Mandapam here on Wednesday.

see more..

Uber enhances moto safety with new features and safety kits

19 Mar 2025 | 7:24 PM

New Delhi, Mar 19 (UNI) Ride-sharing company Uber has announced new safety measures for riders and drivers on its two-wheeler offering 'Moto' here on Wednesday.

see more..

BPCL signs MoU with BluJ Aerospace

19 Mar 2025 | 7:04 PM

Kochi, Mar 19 (UNI) In a significant advancement in sustainable aviation, Bharat Petroleum Corporation Limited (BPCL) has entered into a quadripartite Memorandum of Understanding (MoU) with BluJ Aerospace, the Agency for New and Renewable Energy Research and Technology (ANERT), Government of Kerala, and Cochin International Airport Limited (CIAL) to develop the first hydrogen-fueled Vertical Take-off and Landing (VTOL) aircraft ecosystem globally.

see more..

Hyundai announces 3 pc price hike from April

19 Mar 2025 | 6:34 PM

Chennai, Mar 19 (UNI) Passenger car makers Hyundai Motor India Limited (HMIL)
on Wednesay announced an increase of prices up to 3% effective from April 2025.

see more..

IIHL targeting a valuation of USD 50 billion by 2030: Chairman Ashok Hinduja

19 Mar 2025 | 5:49 PM

Kolkata, Mar 19 (UNI) IndusInd International Holdings Chairman Ashok Hinduja has said with the acquisition of Reliance Capital, IndusInd International Holdings Ltd (IIHL) is targeting a valuation of USD 50 billion by 2030.

see more..